Complex, Frail Elderly Presentation Kim Jany Primary Care Pharmacist Surrey and Sussex CSU Working...
-
Upload
bruce-hopkins -
Category
Documents
-
view
212 -
download
0
Transcript of Complex, Frail Elderly Presentation Kim Jany Primary Care Pharmacist Surrey and Sussex CSU Working...
Complex, Frail Elderly Presentation
Kim Jany
Primary Care Pharmacist
Surrey and Sussex CSU
Working for Guildford and Waverley CCG
April 2013
BGS Definition of Frail, Elderly
• Aged over 75, often over 85, with multiple diseases, which may include dementia
• Tend to present to hospital with symptoms such as falls, immobility and confusion
• Their functional reserve is reduced making them additionally vulnerable to developing complications while in hospital
Surrey Facts
• Surrey has a higher proportion of older people compared with England. The 2010 census data shows that Waverley has the highest % of over 85s in Surrey and 2nd highest % of over 65s.
• Life expectancy in Surrey - Guildford and Waverley is high at 84 years for women and 81 years for men, almost two years longer than the average for England.
Kings Report updated Apr 13 medicines management – a top 10
priority for commissioners
• Four out of five people aged over 75 years take a prescription medicine and 36% are taking four or more (Department of Health 2001).
• The average number of medicines prescribed for people aged 60 years and over in England almost doubled from 21.2 to 40.8 items per person per year in the ten years to 2007 (Information Centre 2007).
Age Related Pharmacokinetics
Absorption particularly important to consider the effects of any coprescribed drugs on absorption eg calcium reduces absorption of bisphosphonates, levothyroxine
Distribution reduced volume of distribution of water soluble
drugs, e.g. digoxin (which may lead to increased initial drug concentration)
increased volume of distribution of lipid soluble drugs, e.g. benzodiazepines (which may lead to increased elimination half-life and prolonged effect).
EliminationDrugs metabolised in liveroxidation, reduction and hydroxylation, largely performed by the mixed function oxidases such as cytochrome P450 are reduced as
reduced hepatic blood flow (35% reduction in hepatic blood flow in the elderly)
reduced hepatic volume (hepatic volume is reduced by 28% in men and 44% in women by the age of 91)
Drugs metabolised in the kidney
reduced glomerular function - GFR is reduced by 6 to 10% per decade after the age of 40
reduced tubular function which means that by the age of 90 there may be a 30 to 40% reduction in overall renal function
This results in reduced clearance of drugs which are mainly excreted via filtration at the kidney
Coexisting disease
• Renal failure results in reduced secretion resulting
accumulation of the drug increased length of time to reach steady state plasma
levels (takes approximately 5 half-lives)
• Congestive cardiac failure results in reduced absorption (due to mucosal oedema, reduced
epithelial blood supply and splanchnic vasoconstriction)reduced volume of distribution (due to decreased tissue
perfusion)reduced elimination (due to reduced hepatic blood flow,
reduced oxidising capacity as a result of hypoxia, reduced GFR and increased tubular reabsorption).
Adverse drug reactions
ADRs increase steadily in incidence with age due to
pharmacokinetic and pharmacodynamic changes
impairment of homeostatic mechanismso baroreceptor responseso control of body swayo thirst o volume regulation o glucose and electrolyte controlo Thermoregulation
Studies show that 10% or more of elderly patient hospital admissions are due to ADRs.
Alarm Bell Drugs• NSAIDs – increased risk of bleed, increased risk of
CV and renal complications
• Diuretics – risk of excessive diuresis leading to orthostatic hypotension, dehydration, renal and electrolyte imbalance
• ACE / ARBs - hypotension, angioedema, hyperkalaemia, renal or hepatic impairment
• SSRI – increased risk GI bleed
• Metformin – lactic acidosis – review if Egfr <45ml/min/1.73m² , stop if <30ml/min/1.73m²
Compliance
• An elderly person whose mental function is intact is no more likely to make mistakes with their medication than a younger person.
• Polypharmacy does make errors more likely
• Deliberate non-compliance failing to take prescribed medication as frequently as directed or
not at all
taking a larger dose in the mistaken belief that it will be more therapeutic or lead to a faster cure
hoarding drugs for future unauthorised use
self-prescribing with over-the-counter preparations
Improve adherence
• Explore non-intentional adherence and find solutions with patient
ability to read, swallow, open bottles, use inhaler devices or insulin pens and testing equipment
Try out devices to improve adherence, e.g. haleraids, spacers, medicine record card, large print labels
• Explore reasons for intentional non-adherence
Provide rationale and teaching behind prescriptions where appropriate
Develop plan with patient as to how to proceed e.g. alternative agent, different formulation, different packaging
Mrs EE, 90yrs old
•Lives with daughter
•Forgetful, otherwise good health
•17 medicines, daughter thinks they are too many
•Only taking 4 laxatives!
•Doesn’t like BP tabs thinks they make her drowsy
•Doesn’t remember to take afternoon dose
Discontinued • Intralgin gel • Fybogel sachets • Vitamin BPC caps • Flixonase spray • Doxazosin 2mg • Dipyridamole (b/4 NICE) • Movicol • NaCl irrigation solution
Continued • Thyroxine 50mcg • Bendroflumethiazide 2.5 • Perindopril • Senna • Lactulose • Aspirin • Digoxin • Simvastatin • Timoptol eye drops
Polypharmacy
Polypharmacy itself should be conceptually perceived as a “disease” with potentially more serious complications than those of the diseases these different drugs have been prescribed for
Doran Gafinkel 2010
Guilty or not guilty
Guilty • Discontinue • Reduce dose/frequency/prn • Substitute with a safer drug/formulation,
schedule • Wait and see, review after a period
Not Guilty • Continue
Reducing polypharmacy is everybody’s business
• Focus on patients with the highest medication related risks and morbidities
• For individual patients, focus on the drugs with the highest risks or highest benefits
• Share the workload with others e.g
dieticians/sip feed, TVN/ dressing, incontinence adviser/antiholinergics, CMHT/ antipsychotics, sleep clinics, pain clinics etc
• Patients, Relatives, carers, community pharmacists, OTs nurses etc can monitor drug effects and feedback
Establish the patient’s overall care goals
Treat the patient not just the disease!
•What outcomes are we working towards with the patient?
•Medicines optimisation goals must fit into overall goal, not work against it
Frail, elderly checklist Ensure an accurate diagnosis
Question necessity for the drug. Avoid inappropriate and over enthusiastic treatment. Consider the patient as a whole.
Can nonpharmacological alternatives be used instead?
Has the most suitable drug been chosen for the patient?
Is the dose correct? Start low and titrate carefully
Consider risk of drug interactions
Ensure a thorough drug history is taken, including OTC medication
Does the patient suffer from another disease for which the drug in question is contraindicated?
Is the treatment regimen as simple as possible?
Has the patient and any carer been counselled about the treatment and do they understand how to take the drugs and for how long?
Appropriate prescribing, Avoidable Waste?
Useful websites / resources
• http://www.cumbria.nhs.uk/ProfessionalZone/MedicinesManagement/Guidelines/StopstartToolkit2011.pdf
• http://www.nhshighland.scot.nhs.uk/Publications/Documents/Guidelines/id1214%20%20Polypharmacy%20Guidance%20for%20Prescribing%20in%20Frail%20Adults.pdf
• http://cks.nice.org.uk/
• http://www.evidence.nhs.uk/
So we know why we should reduce polypharmacy
But how?
Dr Sarah Taylor-Smith,
Frail Elderly Medication Reviews
• By definition these patients have multiple diagnosis. They will collect medications from secondary care out patients and inpatient stays.
• QOF criteria/ targets may add to their polypharmacy.
• Medication review in these patients is an important tool.
Medication Review
• Qof requirement/ GMC guidance• Opportunity to ensure problem coding correct• Can be used to have patient focused
conversation• If on a visit recording may be difficult• Probably already doing this but are we
recording and communicating?
3 C’s for medication review
• Clear
• Considered
• Compliance
Medication review: Clear
Clear: for the GP. Which medication for which diagnosiseg ACE for LVF or BP.
Linking with Emis web
Clear: for the patient, carers, out of hours clinical staff. NHS spine.
Pitfalls- Heart Failure/ Renal failure understanding of terms. Confidentiality
Medication Review: Considered
• Considered: is treatment symptomatic, secondary prevention, primary prevention? Do we need to treat?
• Considered: evidence base in this age group. Adverse affects eg Bp and postural hypotension.
• Considered: Patients wishes.eg Statin in the “world weary.” May give an opening to talk through anticipatory care plan
Medication Review: Compliance
• Compliance: Formulation, stockpiling, dosing schedule, repeat intervals, arrangement with pharmacy.
• Compliance: Care home/nursing home drug error reporting/ audit trail. Medication changes communication.
Clear, Considered, Compliant
• Patient centered approach to reduce medications for complex group of patients
• Clear communication on notes
• On NHS spine
When to review?
• On discharge from hospital
• On arrival to new GP, new care home, nursing home
• QOF yearly review
• Audit?
• Workload implications.